FarmavitaR+

regulatory affairs network

  • Increase font size
  • Default font size
  • Decrease font size
Regulatory Affairs

Approval of the Drug Product in India

E-mail Print PDF

India’s Marketing Regulations of Drugs

Approval of the drug product for import, manufacturing and marketing in India, its demonstration for safety and efficacy in humans is essential. The Rules 122A, 122B and 122D, 122 DA, 122DAA, 122E and Appendix I, IA and VI of Schedule Y of the Drugs & Cosmetics Act, 1945, describes the information/data required for approval of clinical trial and/or to import, manufacture, or market any new drug in the country. However, the requirements for approval of clinical trials and new drugs may vary depending on the nature of new drugs.

The whole 12 pages article is available for download at Repository section of FarmavitaR+.

Read more...
 

Free eCTD Viewer

E-mail Print PDF

Looking for a free eCTD Viewer?

Release Announcement: FREE eCTD Viewer - Your eCTD Viewing Solution.

http://ectdoffice.com/release-announcement-free-ectd-viewer.aspx

Mono Software and PRS today announced the release of the FREE eCTD Office eCTD Viewer - stand-alone, super-fast, easy to use Windows desktop application for viewing and understanding the granularity and the lifecycle of electronic submissions prepared in the eCTD (Electronic Common Technical Document) format.

Read more...
 

LORENZ Group at International Conference on Good Documentation Practice in Regulatory Procedures

E-mail Print PDF

LORENZ Group at International Conference on Good Documentation Practice in Regulatory Procedures

Lorenz Group has been developing innovative software solutions for Life Sciences for more than 20 years and is major e-CTD provider for the EU, Japan and U.S.

 

Read more...
 

DCP Slots at Malta

E-mail Print PDF

Malta as Reference Member State in the Decentralised Procedure

Since 2007 the Medicines Authority is accepting applications as Reference Member State in the Decentralised Procedure.

Until further notice, the applications considered will be those for solid oral dosage forms and oral solutions in accordance with article 10 of Directive 2001/83/EC, as amended.

To be able to consider such applications, some information is requested to enable the Medicines Authority to assess whether to accept the submission of an application for a Marketing Authorisation or not. The Request Form on the CMDh website should be filled in and sent to the Medicines Authority at least 6 months before the proposed submission date. The requests should be sent by e-mail directly to the CMDh (MRP/DCP) contact point with a copy to the e-mail address This e-mail address is being protected from spambots. You need JavaScript enabled to view it . 

The slots for the 20 procedures planned for 2010 are all booked. A few procedures are on the waiting list should slots become available in case of cancellation by the applicants.

Currently the Medicines Authority is filling in slots for 2011 - 2012. Please send in the pre-submission forms in due time for consideration, at least six months before proposed submission date. Once you are given a slot, you are requested to inform the Medicines Authority immediately should you not be able for any reason to submit in the agreed timeline. The Medicines Authority should be informed in good time about any problems encountered that may lead to postponement or cancellation of the slot that is granted.

Information and guidance documents on the decentralised procedure can be found on the CMDh website.

Public assessment reports of products authorised with procedures where Malta is RMS are being made available on http://www.medicinesauthority.gov.mt/par.html

Information source: www.medicinesauthority.gov.mt

 

Banishment of unlicensed herbal remedies in the UK

E-mail Print PDF

Banishment of unlicensed herbal remedies in the UK

 

Thousands of patients in the UK facing the decision about the banning of more than 200 herbal products. For some, this decision is discriminatory and shameful. The same measures are planned for the rest of the EU in accordance with new directive from 2004 (part which concerns herbal products) - from 1 May 2011 all herbal products in the UK must be licensed or prescribed by a registered herb practitioner. This is connected with the concern over adverse events in these products.

Read more...
 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  5 
  •  6 
  •  7 
  •  8 
  •  9 
  •  10 
  •  Next 
  •  End 
  • »


Page 1 of 13
Banner


Login With Facebook

Regulatory Network

Members : 851
Content : 240
Web Links : 5
Content View Hits : 699279

Who's Online

We have 64 guests online

Featured Partners

Regulanet - regulatory affairs consortium

regulanet®: Local representation for Global Regulatory Affairs

 

Tarius - Regulatory Intelligence Databases

Farmavita.Net - pharmaceutical lisensing network

Pharmaceutical Licensing and technology transfer

 

Authnetic and secured web site

 

Increase your website traffic with Attracta.com


Featured Event

150x150WDS-Banner-Farm

Featured Event

KSLS11_150x150_stat


Active Groups

{captcha}